HBM BioCapital with a committed capital of $ 170 million is a Cayman Islands limited partnership investing in private companies in the emerging pharma, biotechnology, medical devices and diagnostics industries. HBM BioCapital usually invests between $5 million to $10 million. Larger transactions are shared with HBM BioVentures. Investors in HBM BioCapital are HBM BioVentures, larger institutional investors and pharma entrepreneurs.